MiMedx Group, Inc. (MDXG)
4.28
-0.05
(-1.15%)
USD |
NASDAQ |
Aug 24, 16:00
4.28
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Shareholders Equity (Quarterly) : 216.00M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 216.00M |
| March 31, 2026 | 242.94M |
| December 31, 2025 | 256.55M |
| September 30, 2025 | 238.95M |
| June 30, 2025 | 216.62M |
| March 31, 2025 | 202.78M |
| December 31, 2024 | 193.11M |
| September 30, 2024 | 181.01M |
| June 30, 2024 | 168.04M |
| March 31, 2024 | 155.73M |
| December 31, 2023 | 142.72M |
| September 30, 2023 | 93.82M |
| June 30, 2023 | 79.83M |
| March 31, 2023 | 74.55M |
| December 31, 2022 | 74.51M |
| September 30, 2022 | 72.97M |
| June 30, 2022 | 78.89M |
| March 31, 2022 | 85.06M |
| December 31, 2021 | 92.58M |
| September 30, 2021 | 86.69M |
| June 30, 2021 | 85.36M |
| March 31, 2021 | 83.98M |
| December 31, 2020 | 91.42M |
| September 30, 2020 | 103.98M |
| June 30, 2020 | 22.86M |
| Date | Value |
|---|---|
| March 31, 2020 | 30.34M |
| December 31, 2019 | 34.40M |
| September 30, 2019 | 39.58M |
| June 30, 2019 | 24.68M |
| March 31, 2019 | 38.35M |
| December 31, 2018 | 49.66M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 73.80M |
| September 30, 2017 | 142.47M |
| June 30, 2017 | 147.27M |
| March 31, 2017 | 129.04M |
| December 31, 2016 | 133.00M |
| September 30, 2016 | 123.28M |
| June 30, 2016 | 121.60M |
| March 31, 2016 | 114.24M |
| December 31, 2015 | 107.99M |
| September 30, 2015 | 100.52M |
| June 30, 2015 | 93.24M |
| March 31, 2015 | 86.40M |
| December 31, 2014 | 89.33M |
| September 30, 2014 | 81.26M |
| June 30, 2014 | 74.49M |
| March 31, 2014 | 76.24M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 137.28M |
| Perspective Therapeutics, Inc. | 323.86M |
| ABVC BioPharma, Inc. | 10.29M |
| Enovis Corp. | 1.477B |
| Edwards Lifesciences Corp. | 10.62B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 281.00M |
| Total Liabilities (Quarterly) | 65.00M |
| Debt to Equity Ratio | 0.0797 |
| Current Ratio | 5.334 |
| Net Debt Paydown Yield | 0.05% |